Clarus Ventures II, LLC, 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), sold 233,990 shares at $3.77 ($882K) on 2010-01-11, disclosed to the SEC on 2010-01-13.
Scheduled sale ($882k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AERI | SELL | 2014-12-24 | $1.5M | — | Filing → |
| ACHN | BUY | 2010-08-20 | $12.1M | — | Filing → |